Clinical findings and natural history of prader-willi syndrome

Management of Prader-Willi Syndrome: Third Edition

Volumn , Issue , 2006, Pages 3-48

  Butler, Merlin G ^a,b   Hanchett, Jeanne M ^c,d   Thompson, Travis ^e  

^a Section of Medical Genetics and Molecular Medicine   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d Children's Institute of Pittsburgh   (United States)

^e Minnesota Autism Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 66549127143     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-33536-0_1     Document Type: Chapter

References (140)

1. Afifi AK, Zellweger H. Pathology of muscular hypotonia in the Prader-Willi syndrome. Journal of Neurological Sciences. 1969;9:49-61.
2. Akefeldt A, Tornhage CJ, Gillberg C. A woman with Prader-Willi syndrome gives birth to a healthy baby girl. Developmental Medicine and Child Neurology. 1999;41(11):789-790.
3. Angulo M, Castro-Magana M, Mazur B, Canas JA, Vitollo PM, Sarrantonio M. Growth hormone secretion and effects of growth hormone therapy on growth velocity and weight gain in children with Prader-Willi syndrome. Journal of Pediatric Endocrinology and Metabolism. 1996;9(3):393-400.
4. Arens R, Omlin KJ, Livingston FR, Liu J, Keens TG, Ward SL. Hypoxic and hypercapnic ventilatory responses in Prader-Willi syndrome. Journal of Applied Physiology. 1994;77:2224-2230.
5. Barghava SA, Putnam PE, Kocoshis SA, Rowe M, Hanchett JM. Rectal bleeding in Prader-Willi syndrome. Pediatrics. 1996;97(2):265-267.
6. Barron J, Sandman CA. Paradoxical excitement to sedative-hypnotics in mentally retarded clients. American Journal of Mental Deficiency. 1985;90(2):124-129.
7. Bier DM, Kaplan SL, Havel RJ. The Prader-Willi syndrome: regulation of fat transport. Diabetes. 1977;26:874-881.
8. Bittel DC, Kibiryeva N, Talebizadeh Z, Butler MG. Microarray analysis of gene/transcript expression in Prader-Willi syndrome: deletion versus UPD. Journal of Medical Genetics. 2003;40:568-574.
9. Bittel DC, Kibiryeva N, Talebizadeh Z, Driscoll DJ, Butler MG. Microarray analysis of gene/transcript expression in Angelman syndrome: deletion versus UPD. Genomics. 2005;85:85-91.
10. Bray GA. Obesity illustrated. In: Bray GA, ed. An Atlas of Obesity and Weight Control. London: Parthenon Publishing Group; 2003.
11. Bray GA, Dahms WT, Swerdloff RS, Fiser RH, Atkinson RL, Carrel RE. The Prader-Willi syndrome. Medicine. 1983;62:59-80.
12. Buiting K, Färber C, Kroisel P, et al. Imprinting centre deletions in two PWS families: implications for diagnostic testing and genetic counseling. Clinical Genetics. 2000;58:284-290.
13. Buiting K, Groß S, Lich C, Gillessen-Kaesbach G, El-Maarri O, Horsthemke B. Epimutations in Prader-Willi and Angelman syndrome: a molecular study of 136 patients with an imprinting defect. American Journal of Human Genetics. 2003;72:571-577.
14. Burman P, Ritzén EM, Lindgren AC. Endocrine dysfunction in Prader-Willi syndrome: a review with special reference to GH. Endocrine Reviews. 2001;22(6):787-799.
15. Butler JV, Whittington JE, Holland AJ, Boer H, Clarke D, Webb T. Prevalance of, and risk factors for, physical ill-health in people with Prader-Willi syndrome: a population-based study. Developmental Medicine and Child Neurology. 2002;44(4):248-255.
16. Butler MG. Hypopigmentation: a common feature of Prader-Labhart-Willi syndrome. American Journal of Human Genetics. 1989;45:140-146.
17. Butler MG. Prader-Willi syndrome: current understanding of cause and diagnosis. American Journal of Medical Genetics. 1990;35(3):319-332.
18. Butler MG. A 68-year-old white female with Prader-Willi syndrome. Clinical Dysmorphology. 2000;9(1):65-67.
19. Butler MG. Imprinting disorders: non-Mendelian mechanisms affecting growth. Journal of Pediatric Endocrinology and Metabolism. 2002;5:1279-1288.
20. Butler MG, Bittel DC, Kibiryeva N, Talebizadeh Z, Thompson T. Behavioral differences among subjects with Prader-Willi syndrome and type I or type II deletion and maternal disomy. Pediatrics. 2004;113(3 Pt1):565-573.
21. Butler MG, Bittel DC, Talebizadeh Z. Plasma peptide YY and ghrelin levels in infants and children with Prader-Willi syndrome. Journal of Pediatric Endocrinology and Metabolism. 2004;17(9):1177-1184.
22. Butler MG, Butler RI, Meaney FJ. The use of skinfold measurements to judge obesity during the early phase of Prader-Labhart-Willi syndrome. International Journal of Obesity. 1988;12:417-422.
23. Butler MG, Carlson MG, Schmidt DE, Feurer ID, Thompson T. Plasma cholecystokinin levels in Prader-Willi syndrome and obese subjects. American Journal of Medical Genetics. 2000;95(1):67-70.
24. Butler MG, Dasouki M, Bittel D, Hunter S, Naini A, DiMauro S. Coenzyme Q10 levels in Prader-Willi syndrome: comparison with obese and non-obese controls. American Journal of Medical Genetics. 2003;119A(2):168-171.
25. Butler MG, Dasouki M, Hunter S, Gregersen N, Naini A, DiMauro S. A child with Prader-Willi syndrome and ethylmalonic aciduria. 4th International Prader-Willi Syndrome Scientific Conference, St. Paul, MN; June 27, 2001.
26. Butler MG, Haber L, Mernaugh R, Carlson MG, Price R, Feurer ID. Decreased bone mineral density in Prader-Willi syndrome: comparison with obese subjects. American Journal of Medical Genetics. 2001;103:216-222.
27. Butler MG, Haynes JL, Meaney FJ. Intra-familial and mid-parental child correlations and heritability estimates of anthropometric measurements in Prader-Willi syndrome families. Dysmorphology and Clinical Genetics. 1990;4:2-6.
28. Butler MG, Kaler SG, Meaney FJ. Metacarpophalangeal pattern profile analysis in Prader-Willi syndrome. Clinical Genetics. 1982;22:315-320.
29. Butler MG, Kessler RM. Positron emission tomography of three adult patients with Prader-Willi syndrome. Dysmorphology and Clinical Genetics. 1992;6:30-31.
30. Butler MG, Meaney FJ. An anthropometric study of 38 individuals with Prader-Labhart-Willi syndrome. American Journal of Medical Genetics. 1987;26:445-455.
31. Butler MG, Meaney FJ. Standards for selected anthropometric measurements in Prader-Willi syndrome. Pediatrics. 1991;88:853-860.
32. Butler MG, Meaney FJ, Palmer CG. Clinical and cytogenetic survey of 39 individuals with Prader-Labhart-Willi syndrome. American Journal of Medical Genetics. 1986;23(3):793-809.
33. Butler MG, Moore J, Morawiecki A, Nicolson M. Comparison of leptin levels in Prader-Willi syndrome and control individuals. American Journal of Medical Genetics. 1998;75(1):7-12.
34. Butler MG, Murrell JE, Greene HL. Amino acid levels in Prader-Willi syndrome and obese individuals. Dysmorphology and Clinical Genetics. 1990;4:18-22.
35. Butler MG, Palmer CG. Parental origin of chromosome 15 deletion in Prader-Willi syndrome. Lancet. 1983;1:1285-1286.
36. Butler MG, Swift LL, Hill JO. Fasting plasma lipid, glucose and insulin levels in Prader-Willi syndrome and obese individuals. Dysmorphology and Clinical Genetics. 1990;4:23-26.
37. Butler MG, Thompson T. Prader-Willi syndrome: clinical and genetic findings. The Endocrinologist. 2000;10:3S-16S.
38. Butler MG, Weaver DD, Meaney FJ. Prader-Willi syndrome: are there population differences? Clinical Genetics. 1982;22(5):292-294.
39. Carpenter PK. Prader-Willi syndrome in old age. Journal of Intellectual Disabilities Research. 1994;38:529-531.
40. Cassidy SB. Prader-Willi syndrome. Current Problems in Pediatrics. 1984;14:1-55.
41. Cassidy SB. Prader-Willi syndrome: characteristics, management, and etiology. The Alabama Journal of Medical Sciences. 1987;24(2):169-175.
42. Cassidy SB. Prader-Willi syndrome. Journal of Medical Genetics. 1997;34(11):917-923.
43. Cassidy SB, Dykens E, Williams CA. Prader-Willi and Angelman syndromes: sister imprinted disorders. American Journal of Medical Genetics. 2000;97(2):136-146.
44. Cassidy SB, Forsythe M, Heeger S, et al. Comparison of phenotype between patients with Prader-Willi syndrome due to deletion 15q and uniparental disomy 15. American Journal of Medical Genetics. 1997;68:433-440.
45. Cassidy SB, Rubin KG, Mukaida CS. Genital abnormalities and hypogonadism in 105 patients with Prader-Willi syndrome. American Journal of Medical Genetics. 1987;28:922-923.
46. Chai JH, Locke DP, Eichler EE, Nicholls RD. Evolutionary transposition of 4 unique genes mediated by flanking duplicons in the Prader-Willi/Angelman syndrome deletion region. American Journal of Human Genetics. 2002;71:A395.
47. Chasalow FI, Blethen SL, Tobash JG, Myles D, Butler MG. Steroid metabolic disturbances in Prader-Willi syndrome. American Journal of Medical Genetics. 1987;28:857-864.
48. Creel DJ, Bendel CM, Wiesner GL, Wirtschafter JD, Arthur DC, King RA. Abnormalities of the central visual pathways in Prader-Willi syndrome associated with hypopigmentation. New England Journal of Medicine. 1986;314:1606-1609.
49. Crnic KA, Sulzbacher S, Snow J, Holm VA. Preventing mental retardation associated with gross obesity in the Prader-Willi syndrome. Pediatrics. 1980;66(5):787-789.
50. Cummings DE, Clement K, Purnell JQ, et al. Elevated plasma ghrelin levels in Prader-Willi syndrome. Nature Medicine. 2002;8(7):643-644.
51. Dech B, Budow L. The use of fluoxetine in an adolescent with Prader-Willi syndrome. Journal of the American Academy of Child and Adolescent Psychiatry. 1991;30(2):298-302.
52. Dimitropoulos A, Feurer ID, Butler MG, Thompson T. Emergence of compulsive behavior and tantrums in children with Prader-Willi syndrome. American Journal of Mental Retardation. 2000;106(1):39-51.
53. Dimitropoulos A, Feurer ID, Roof E, et al. Appetitive behavior, compulsivity, and neurochemistry in Prader-Willi syndrome. Mental Retardation and Developmental Disabilities Research Review. 2001;6(2):125-130.
54. Down JL. In: Mental Affections of Childhood and Youth. London: Churchill Publisher; 1887:172.
55. Dunn HG. The Prader-Labhart-Willi syndrome: review of the literature and report of nine cases. Acta Paediatrica Scandinavica Supplement. 1968;186:1-9.
56. Dykens EM. Are jigsaw puzzle skills "spared" in persons with Prader-Willi syndrome? Journal of Child Psychology and Psychiatry. 2002;43(3):343-352.
57. Dykens EM, Cassidy SB, King BH. Maladaptive behavior differences in Prader-Willi syndrome; due to paternal deletion versus maternal uniparental disomy. American Journal of Mental Retardation. 1999;104:67-77.
58. Dykens EM, Leckman JF, Cassidy SB. Obsessions and compulsions in Prader-Willi syndrome. Journal of Child Psychology and Psychiatry. 1996;37:995-1002.
59. Dykens EM, Hodapp RM, Walsh K, Nash LJ. Profiles, correlates, and trajectories of intelligence in Prader-Willi syndrome. Journal of the American Academy of Child and Adolescent Psychiatry. 1992;31(6):1125-1130.
60. Ebert MH, Schmidt DE, Thompson T, Butler MG. Elevated plasma gammaaminobutyric acid (GABA) levels in individuals with either Prader-Willi syndrome or Angelman syndrome. The Journal of Neuropsychiatry and Clinical Neurosciences. 1997;9(1):75-80.
61. Feurer ID, Dimitropoulos A, Stone WL, Butler MG, Thompson T. The latent variable structure of the Compulsive Behavior Checklist in people with Prader-Willi syndrome. Journal of Intellectual Disability Research. 1998;42:472-480.
62. Flament MF, Rapoport JL, Murphy DL, Beng CJ, Lake CR. Biochemical changes during clomipramine treatment of childhood obsessivecompulsive disorder. Archives of General Psychiatry. 1987;44(3):219-225.
63. Flegal KM, Carroll MD, Kucamarski RJ. Overweight and obesity in the United States: prevalence and trends. International Journal of Obesity and Related Metabolic Disorders. 1998;22:39-47.
64. Fox R, Butler MG, Sinatra RB. Visual capacity and Prader-Willi syndrome. Journal of Pediatric Ophthalmology and Strabismus. 1999;36:1-7.
65. Fox R, Yang GS, Feurer ID, Butler MG, Thompson T. Kinetic form discrimination in Prader-Willi syndrome. Journal of Intellectual Disability Research. 2001;45:317-325.
66. Gabreels BA, Swaab DF, de Kleijn DP, et al. Attenuation of the polypeptide 7B2, prohormone convertase PC2, and vasopressin in the hypothalamus of some Prader-Willi patients: indications for a processing defect. Journal of Clinical Endocrinology and Metabolism. 1998;83(2):591-599.
67. Gabreels BA, Swaab DF, Seidah NG, van Duijnhoven HL, Martens GJ, van Leeuwen FW. Differential expression of the neuroendocrine polypeptide 7B2 in hypothalamus of Prader-(Labhart)-Willi syndrome patients. Brain Research. 1994;657(1-2):281-293.
68. Gillessen-Kaesbach G, Robinson W, Lohmann D, Kaya-Westerloh S, Passarge E, Horsthemke B. Genotype-phenotype correlation in a series of 167 deletion and non-deletion patients with Prader-Willi syndrome. Human Genetics. 1995;96(6):638-643.
69. Ginsberg-Fellner F. Growth of adipose tissue in infants, children and adolescents: variations in growth disorders. International Journal of Obesity. 1981;5(6):605-611.
70. Goldstone AP, Brynes AE, Thomas EL, et al. Resting metabolic rate, plasma leptin concentrations, leptin receptor expression, and adipose tissue measured by whole-body magnetic resonance imaging in women with Prader-Willi syndrome. American Journal of Clinical Nutrition. 2002;75(3):468-475.
71. Goldstone AP, Thomas EL, Brynes AE, et al. Visceral adipose tissue and metabolic complications of obesity are reduced in Prader-Willi syndrome female adults: evidence for novel influences on body fat distribution. Journal of Clinical Endocrinology and Metabolism. 2001;86(9):4430-4338.
72. Greenswag LR. Adults with Prader-Willi syndrome: a survey of 232 cases. Developmental Medicine and Child Neurology. 1987;29(2):145-152.
73. Gunay-Aygun M, Heeger S, Schwartz S, Cassidy SB. Delayed diagnosis in patients with Prader-Willi syndrome due to maternal uniparental disomy 15. American Journal of Medical Genetics. 1997;71(1):106-110.
74. Gurr MI, Jung RT, Robinson MP, James WP. Adipose tissue cellularity in man: the relationship between fat cell size and number, the mass and distribution of body fat and the history of weight gain and loss. International Journal of Obesity. 1982;6(5):419-436.
75. Hall BD, Smith DW. Prader-Willi syndrome. A resume of 32 cases including an instance of affected first cousins, one of whom is of normal stature and intelligence. Journal of Pediatrics. 1972;81(2):286-293.
76. Hanchett JM. Menstrual periods in Prader-Willi syndrome women. American Journal of Medical Genetics. 1996;64:577.
77. Hanchett JM, Butler M, Cassidy SB, et al. Age and causes of death in Prader-Willi syndrome patients. American Journal of Medical Genetics. 1996;2:211.
78. Haqq AM, Farooqi IS, O'Rahilly S, et al. Serum ghrelin levels are inversely correlated with body mass index, age, and insulin concentrations in normal children and are markedly increased in Prader-Willi syndrome. Journal of Clinical Endocrinology and Metabolism. 2003;88(1):174-178.
79. Hart PS. Salivary abnormalities in Prader-Willi syndrome. Annals of the New York Academy of Sciences. 1998;842:125-131.
80. Hashimoto T, Mori K, Yoneda Y, et al. Proton magnetic resonance spectroscopy of the brain in patients with Prader-Willi syndrome. Pediatric Neurology. 1998;18(1):30-35.
81. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM. Prevalence of overweight and obesity among U. S. children, adolescents, and adults, 1999-2002. Journal of the American Medical Association. 2004;291(23):2847-2850.
82. Hellings JA, Warnock JK. Self-injurious behavior and serotonin in Prader-Willi syndrome. Psychopharmacology Bulletin. 1994;30:245-250.
83. Hill JO, Kaler M, Spetalnick B, Reed G, Butler MG. Resting metabolic rate in Prader-Willi syndrome. Dysmorphology and Clinical Genetics. 1990;4:27-32.
84. Holm VA. The diagnosis of Prader-Willi syndrome. In: Holm VA, Sulzbacher SJ, Pipes PL, eds. Prader-Willi Syndrome. Baltimore, MD: University Park Press; 1981:27-44.
85. Holm VA, Cassidy SB, Butler MG, Hanchett JM, Greenberg F. Prader-Willi syndrome: consensus diagnostic criteria. Pediatrics. 1993;91:398-402.
86. Hudgins L, Geer JS, Cassidy SB. Phenotypic differences in African Americans with Prader-Willi syndrome. Genetics in Medicine. 1998;1(3):49-51.
87. Iranmenesh A, Lizarralde G, Veldhuis JD. Age and relative adiposity are specific determinants of the frequency and amplitude of growth hormone (GH) secretion bursts and the half-life of endogenous GH in healthy men. Journal of Clinical Endocrinology. 1991;73:1081-1088.
88. Jancar J. Prader-Willi syndrome (hypotonia, obesity, hypogonadism, growth and mental retardation). Journal of Mental Deficiency Research. 1971;15(1):20-29.
89. Joseph B, Egli M, Sutcliffe JS, Thompson T. Possible dosage effect of maternally expressed genes on visual recognition memory in Prader-Willi syndrome. American Journal of Medical Genetics. 2001;105(1):71-75.
90. Kleppe SA, Katsyama KM, Shipley KG, Foushee DR. The speech and language characteristics of children with Prader-Willi syndrome. Journal of Speech and Hearing Disorders. 1990;55(2):300-309.
91. Lamb AS, Johnson WM. Premature coronary artery atherosclerosis in a patient with Prader-Willi syndrome. American Journal of Medical Genetics. 1987;28(4):873-880.
92. Laxova R, Gilderdale S, Ridler MA. An aetiological study of 53 female patients from subnormality hospital and of their offspring. Journal of Mental Deficiency Research. 1973;17:193-225.
93. Ledbetter DH, Riccardi VM, Airhart SD. Deletions of chromosome 15 as a cause of the Prader-Willi syndrome. New England Journal of Medicine. 1981;304(6):325-329.
94. Lee P D K. Endocrine and metabolic aspects of Prader-Willi syndrome. In: Greenswag LR, Alexander RC, eds. Management of Prader-Willi Syndrome. 2nd ed. New York, NY: Springer-Verlag; 1995.
95. Lee P D K, Wilson DM, Hintz RL, Rosenfield RG. Growth hormone treatment of short stature in Prader-Willi syndrome. Journal of Pediatric Endocrinology. 1987;2:31-34.
96. Lindgren AC, Hagenas L, Muller J, et al. Growth hormone treatment of children with Prader-Willi syndrome affects linear growth and body composition favourably. Acta Paediatrica. 1998;87:28-31.
97. Martin A, State M, Anderson GM, et al. Cerebrospinal fluid levels of oxytocin in Prader-Willi syndrome: a preliminary report. Biology and Psychiatry. 1998;44(12):1349-1352.
98. Meaney FJ, Butler MG. Craniofacial variation and growth in the Prader-Labhart-Willi syndrome. American Journal of Physical Anthropology. 1987;74(4):459-464.
99. Meaney FJ, Butler MG. Assessment of body composition in Prader-Labhart-Willi syndrome. Clinical Genetics. 1989;35(4):300.
100. Meaney FJ, Butler MG. Characterization of obesity in the Prader-Labhardt-Willi syndrome: fatness patterning. Medical Anthropology Quarterly. 1989;3:294-305.
101. Meaney FJ, Butler MG. The developing role of anthropologists in medical genetics: anthropometric assessment of the Prader-Labhardt-Willi syndrome as an illustration. Medical Anthropology. 1989;10:247-253.
102. Mitchell J, Schinzel A, Langlois S, et al. Comparison of phenotype in uniparental disomy and deletion Prader-Willi syndrome: sex specific differences. American Journal of Medical Genetics. 1996;65(2):133-136.
103. Murphy DL, Zohar J, Benkelfat C, Pato MT, Pigott TA, Insel TR. Obsessivecompulsive disorder as a 5-HT subsystem-related behavioral disorder. British Journal of Psychiatry Supplement. 1989;8:15-24.
104. Nardella MT, Sulzbacher S, Worthington-Roberts BS. Activity levels of persons with Prader-Willi syndrome. American Journal of Mental Deficiency. 1983;87:498-505.
105. Nelson RA, Huse DM, Holman RT, et al. Nutrition, metabolism, body composition, and response to the ketogenic diet in Prader-Willi syndrome. In: Holm VA, Sulzbacher S, Pipes PL, eds. Prader-Willi Syndrome. Baltimore, MD: University Park Press; 1981:105-120.
106. Nicholls RD, Knepper, JL. Genome organization, function, and imprinting in Prader-Willi and Angelman syndromes. Annual Review of Genomics and Human Genetics. 2001;2:153-175.
107. Nicholls RD, Knoll J H M, Butler MG, Karum S, Lalande M. Genetic imprinting suggested by maternal heterodisomy in nondeletion Prader-Willi syndrome. Nature. 1989;342:281-285.
108. Nixon GM, Brouillette RT. Sleep and breathing in Prader-Willi syndrome. Pediatrics and Pulmonology. 2002;34:209-217.
109. Pietrobelli A, Allison DB, Faith MS, et al. Prader-Willi syndrome: relationship of adiposity to plasma leptin levels. Obesity Research. 1998;6(3):196-201.
110. Prader A, Labhart A, Willi H. Ein syndrom von adipositas, kleinwuchs, kryptorchismus und oligophrenie nach myatonieartigem zustand im neugeborenenalter. Schweizerische Medizinische Wochenschrift. 1956;86:1260-1261.
111. Reed T, Butler MG. Dermatologic features in Prader-Willi syndrome with respect to chromosomal findings. Clinical Genetics. 1984;25:341-346.
112. Ritzen EM, Bolme P, Hall K. Endocrine physiology and therapy in Prader-Willi syndrome. In: Cassidy SB, ed. Prader-Willi Syndrome and Other Chromosome 15q Deletion Disorders. New York, NY: Springer-Verlag; 1992:153-169.
113. Roof E, Stone W, MacLean W, Feurer ID, Thompson T, Butler MG. Intellectual characteristics of Prader-Willi syndrome: comparison of genetic subtypes. Journal of Intellectual Disabilities Research. 2000;44:1-6.
114. Rubin K, Cassidy SB. Hypogonadism and osteoporosis. In: Greenswag LR, Alexander RC, eds. Management of Prader-Willi Syndrome. New York, NY: Springer; 1988.
115. Schoeller DA, Levitsky LL, Bandini LG, Dietz WW, Walczak A. Energy expenditure and body composition in Prader-Willi syndrome. Metabolism. 1988;37(2):115-120.
116. Schulze A, Mogensen, H, Hamborg-Petersen B, Graem N, Ostergaard JR, Brodum-Nielsen K. Fertility in Prader-Willi syndrome: a case report with Angelman syndrome in the offspring. Acta Paediatrica. 2001;90(4):455-459.
117. Schwartz RS, Brunzell JD, Bierman EL. Elevated adipose tissue lipoprotein lipase in the pathogenesis of obesity in Prader-Willi syndrome. In: Holm VA, Sulzbacher S, Pipes PL, eds. Prader-Willi Syndrome. Baltimore, MD: University Park Press; 1981:137-143.
118. Spritz RA, Bailin T, Nicholls RD, et al. Hypopigmentation in Prader-Willi syndrome correlates with P gene deletion but not with haplotype of the hemizygous P allelle. American Journal of Medical Genetics. 1997;71:57-62.
119. Stein DJ, Keating J, Zar HJ. A survey of the phenomenon and pharmacotherapy of compulsive and impulsive-aggressive symptoms in Prader-Willi syndrome. Journal of Neuropsychiatry. 1994;6:23-29.
120. Sulzbacher S, Crnic KA, Snow J. Behavior and cognitive disabilities in Prader-Willi syndrome. In: Holm VA, Sulzbacher SJ, Pipes PL, eds. Prader-Willi Syndrome. Baltimore, MD: University Park Press; 1981:147-159.
121. Swaab DF. Prader-Willi syndrome and the hypothalamus. Acta Paediatrica Supplement. 1997;423:50-54.
122. Symons FJ, Butler MG, Sanders MD, Feurer ID, Thompson T. Self-injurious behavior and Prader-Willi syndrome: behavioral forms and body locations. American Journal of Mental Retardation. 1999;104:260-269.
123. Talebizadeh Z, Butler MG. Insulin resistance and obesity-related factors in Prader-Willi syndrome: comparison with obese subjects. Clinical Genetics. 2004;67:230-239.
124. Talebizadeh Z, Kibiryeva N, Bittel DC, Butler MG. Ghrelin, peptide YY and their receptors: gene expression in brain subjects with and without Prader-Willi syndrome. International Journal of Molecular Medicine. 2005;15:707-711.
125. Taylor RL. Cognitive and behavioral characteristics. In: Caldwell ML, Taylor RL, eds. Prader-Willi Syndrome: Selected Research and Management Issues. 2nd ed. New York, NY: Springer-Verlag; 1988.
126. Thompson T, Butler MG. Prader-Willi syndrome: clinical, behavioral and genetic findings. In: Wolraich ML, ed. Disorders of Development and Learning. 3rd ed. Hamilton, Ontario: B. C. Decker, Inc.; 2003.
127. Thompson T, Butler MG, MacLean WE, Joseph B. Prader-Willi syndrome: genetics and behavior. Peabody Journal of Education. 1996;71:187-212.
128. Thompson T, Gray DB. Destructive behavior in developmental disabilities: diagnosis and treatment. In: Thompson T, Gray DB, eds. Behavior in Developmental Disabilities. Thousand Oaks, CA: Sage Publishers; 1994.
129. Thornton L, Dawson KP. Prader-Willi syndrome in New Zealand: a survey of 36 affected people. New Zealand Medical Journal. 1990;103(885):97-98.
130. Ungaro P, Christian SL, Fantes JA, et al. Molecular characterization of four cases of intrachromosomal triplication of chromosome 15q11-q14. Journal of Medical Genetics. 2001;38(1):26-34.
131. van Lieshout CF, De Meyer RE, Curfs LM, Fryns JP. Family contexts, parental behavior, and personality profiles of children and adolescents with Prader-Willi, fragile X, or Williams syndrome. Journal of Child Psychology and Psychiatry. 1998;39(5):699-710.
132. Vogels A, Matthijs G, Legius E, Devriendt K, Fryns JP. Chromosome 15 maternal uniparental disomy and psychosis in Prader-Willi syndrome. Journal of Medical Genetics. 2003;40(1):72-73.
133. Warnock JK, Clayton AH, Shaw HA, O'Donnell T. Onset of menses in two adult patients with Prader-Willi syndrome treated with fluoxetine. Psychopharmacology Bulletin. 1995;11:239-242.
134. Warnock JK, Kestenbaum T. Pharmacologic treatment of severe skinpicking behaviors in Prader-Willi syndrome. Two case reports. Archives of Dermatology. 1992;128(12):1623-1625.
135. Warren J, Hunt E. Cognitive processing in children with Prader-Willi syndrome. In: Holm VA, Sulzbacher SJ, Pipes PL, eds. Prader-Willi Syndrome. Baltimore, MD: University Park Press; 1981:161-178.
136. Wharton RH, Loechner KJ. Genetic and clinical advances in Prader-Willi syndrome. Current Opinions in Pediatrics. 1996;8:618-624.
137. Whitman BY, Accardo P. Emotional symptoms in Prader-Willi syndrome adolescents. American Journal of Medical Genetics. 1987;28(4):897-905.
138. Yoshii A, Krishnamoorthy KS, Grant PE. Abnormal cortical development shown by 3D MRI in Prader-Willi syndrome. Neurology. 2002;59(4):644-645.
139. Young W, Khan F, Brandt R, Savage N, Razek AA, Huang Q. Syndromes with salivary dysfunction predispose to tooth wear: case reports of congenital dysfunction of major salivary glands, Prader-Willi, congenital rubella, and Sjogren's syndromes. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics. 2001;92(1):38-48.
140. Zellweger H, Schneider HJ. Syndrome of hypotonia- hypomentiahypogonadismobesity (HHHO) or Prader-Willi syndrome. American Journal of Diseases of Children. 1968;115(5):588-598.